Chloroquine-resistant Plasmodium falciparum infections among UK travellers returning with malaria after chloroquine prophylaxis.
about
Drugs for preventing malaria in travellersDrugs for preventing malaria in travellersFive years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll outEfficacy of two versus three-day regimens of dihydroartemisinin-piperaquine for uncomplicated malaria in military personnel in northern Cambodia: an open-label randomized trialProbucol-Induced α-Tocopherol Deficiency Protects Mice against Malaria InfectionAssessment of Markers of Antimalarial Drug Resistance in Plasmodium falciparum Isolates from Pregnant Women in Lagos, NigeriaAn observational study of malaria in British travellers: Plasmodium ovale wallikeri and Plasmodium ovale curtisi differ significantly in the duration of latencyThe Malaria TaqMan Array Card Includes 87 Assays for Plasmodium falciparum Drug Resistance, Identification of Species, and Genotyping in a Single Reaction.Molecular surveillance for drug-resistant Plasmodium falciparum in clinical and subclinical populations from three border regions of Burma/Myanmar: cross-sectional data and a systematic review of resistance studiesMarkers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolatesDynamics of pfcrt alleles CVMNK and CVIET in chloroquine-treated Sudanese patients infected with Plasmodium falciparum.Rapid identification of chloroquine and atovaquone drug resistance in Plasmodium falciparum using high-resolution melt polymerase chain reactionEx vivo activity of endoperoxide antimalarials, including artemisone and arterolane, against multidrug-resistant Plasmodium falciparum isolates from Cambodia.Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine.Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.Various pfcrt and pfmdr1 genotypes of Plasmodium falciparum cocirculate with P. malariae, P. ovale spp., and P. vivax in northern Angola.Attenuation of Plasmodium falciparum in vitro drug resistance phenotype following culture adaptation compared to fresh clinical isolates in Cambodia.Assessment of the molecular marker of Plasmodium falciparum chloroquine resistance (Pfcrt) in Senegal after several years of chloroquine withdrawalAssessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study.The feasibility of malaria elimination in South Africa.Cluster of falciparum malaria cases in UK airport.Novel pfdhps haplotypes among imported cases of Plasmodium falciparum malaria in the United Kingdom.Culture-adapted Plasmodium falciparum isolates from UK travellers: in vitro drug sensitivity, clonality and drug resistance markers.Amodiaquine resistance in Plasmodium falciparum malaria in Afghanistan is associated with the pfcrt SVMNT allele at codons 72 to 76.Detection of single-nucleotide polymorphisms in Plasmodium falciparum by PCR primer extension and lateral flow immunoassay.In-vivo efficacy of amodiaquine-artesunate in children with uncomplicated Plasmodium falciparum malaria in western Kenya.
P2860
Q21032525-914BC01C-18ED-4DCA-99FC-C80A5094C147Q24186690-D1B08C28-FF48-4A9A-A6FB-95EEE64E2FD5Q28477515-856EF2F4-5F9D-4E01-887B-99AC24F0ECA8Q28541521-BAD6321E-F146-414A-AB4E-0F2CAE0B1B88Q28547411-051E26EA-61E4-4678-BD4E-57E93813F360Q28552844-60209315-55C8-42EC-BF2D-0B53AE4489A1Q28689829-4A5B015B-E71C-4D24-940C-2906B215B3F0Q30253026-37806D6D-A103-4CDE-83CA-CB06A6804483Q30568502-0B1EB303-4EE8-4540-9A7A-029FA0F09EABQ33752129-1873B4BE-5B18-4EB6-88B4-31D631B41CCDQ33763957-A7118399-A550-4455-9ECC-382C9C74052BQ33895143-0D738D29-BDD6-4F5A-A20F-E79D16C32A79Q34298916-C6EF223E-DCFF-4EEE-8FEB-59089B1224FFQ35545210-7E03A0D0-A3FE-4AC5-A8C3-E2C597580633Q35859975-B7E5A8D9-5E0A-4FB9-BFC1-63A3508F080BQ36276785-B86FC428-8DF7-4716-B8E7-3978A89CB8B3Q36340905-30548834-5273-41DF-AD1C-A84691D3C876Q36450797-296F7529-1FAB-48D1-AC60-D0A1F5120D33Q36531342-34648EE9-EC0E-4695-8E6C-DE2D9692E5B1Q36614286-D58E8A7F-E0F8-4AA9-8ADD-2FC0C35BAF7CQ37009516-F7D6EE8D-72B6-4CF7-A143-A16AF1F7E6F8Q37274739-41A1461F-C537-47BE-A8A9-50376B730241Q37357025-870AC21F-2314-4F35-81E9-C243DCAB3886Q38906519-E964459F-BAE3-4915-985E-FED8D08DF111Q39257587-B92BDF7D-D60C-4540-ADE7-DE64FDFE5007Q40005806-69F43BA0-6CF8-4B34-A504-8995FB95ACFF
P2860
Chloroquine-resistant Plasmodium falciparum infections among UK travellers returning with malaria after chloroquine prophylaxis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Chloroquine-resistant Plasmodi ...... after chloroquine prophylaxis.
@en
Chloroquine-resistant Plasmodi ...... after chloroquine prophylaxis.
@nl
type
label
Chloroquine-resistant Plasmodi ...... after chloroquine prophylaxis.
@en
Chloroquine-resistant Plasmodi ...... after chloroquine prophylaxis.
@nl
prefLabel
Chloroquine-resistant Plasmodi ...... after chloroquine prophylaxis.
@en
Chloroquine-resistant Plasmodi ...... after chloroquine prophylaxis.
@nl
P2093
P921
P356
P1476
Chloroquine-resistant Plasmodi ...... after chloroquine prophylaxis.
@en
P2093
Justin F Doherty
Margaret Armstrong
Peter L Chiodini
Thomas Haustein
P304
P356
10.1093/JAC/DKM104
P407
P577
2007-05-02T00:00:00Z